Team

Working at optellum

Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back. We are a fast-growing company with offices in Oxford in the United Kingdom and the Texas Medical Center in Houston, United States.

CAREERS

Leadership Team

Our leadership team of award-winning machine learning, medical device and clinical experts met at University of Oxford’s world-renowned computer vision laboratory. They have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We also work closely with global leading clinicians – authors of lung cancer guidelines in the USA, EU and the UK.

Václav Potěšil PhD

CEO

Václav Potěšil PhD

CEO

Václav Potěšil is a co-founder of Optellum, a startup formed by a team of AI, medical imaging and clinical experts who met at the University of Oxford.

Václav holds an Oxford PhD in Computer Vision (lung cancer therapy planning) in collaboration with Siemens Molecular Imaging and Mirada Medical. He developed and launched pioneering medical robotics devices as Global Product Manager at Hocoma, the global market leader in neuro-rehabilitation exoskeletons. He has worked in ten countries and speaks seven languages.

Martina Miškufová EngD

Chief Finance and Operations Officer

Martina Miškufová EngD

Chief Finance and Operations Officer

After her doctorate studies, Martina spent nine years with McKinsey and Co., working with healthcare payors and providers, as well as pharmaceutical and medical device companies.

Her primary focus was value-based care. She led the design and implementation of healthcare payment reform initiatives in several US payor organizations as well as working with European payors on models of the financial impact of innovative programmes. Her passion is in improving patient outcomes and optimizing value in healthcare in a data-driven way.

Professor Lutz Freitag MD

Chief Medical Officer

Professor Lutz Freitag MD

Chief Medical Officer

Professor Lutz Freitag MD FCCP is a globally renowned and respected interventional pulmonologist. He brings 40 years’ experience from leading hospitals (e.g. department chief Ruhrlandklinik, West German Lung Center), medical schools (Professor at Essen, Visiting Professor at Harvard, Stanford, Tulane, Wenzhou) and the device industry.

Lutz is a named inventor on over 200 patents. His commercial experience includes roles as the Founder, Chief Medical Officer (CMO) and Board of Directors (BoD) member at Breathe Technologies Inc (acquired by Hillrom); and as the CMO and BoD member at Pulmonx Corp (IPOed as NASDAQ:LUNG), having made key contributions over 15 years to the first medical device treatment for severe emphysema patients approved by the FDA.

Timor Kadir PhD

Chief Science and Technology Officer

Timor Kadir PhD

Chief Science and Technology Officer

After graduating with a DPhil in Computer Vision from Oxford University, Timor has accumulated over 18 years in artificial intelligence and machine learning applied to medical devices and software applications. He has extensive experience in technology development, product strategy and intellectual property management as well as commercialisation and business development. He has held key roles at Motorola, Siemens Healthcare and Mirada Medical and has published over 70 peer-reviewed papers, and filed over 30 patents.

Professor Sir Michael Brady

Chair of the Board

Professor Sir Michael Brady

Chair of the Board

Professor Sir Michael Brady FRS FREng FMedSci is one of the world’s leading authorities in the field of image analysis, with a strong emphasis on medical image analysis.

He has contributed algorithms for image segmentation, registration and feature detection. He developed a highly influential mathematical model of the fluence of X-rays through the female breast as a basis for analysis of mammographic images.

Michael has a strong commitment to the commercialization of scientific research and is involved with numerous start-ups in the field of medical imaging. In addition to his numerous academic fellowships and prizes, he received a knighthood in 2003 for services to engineering.

Jérôme Declerck

VP of R&D

Jérôme Declerck

VP of R&D

Jerome is responsible for research and development, clinical collaborations and trials.

He has been delivering innovative medical software solutions for over 25 years thanks to key roles held at Mirada Solutions, CTI Molecular Imaging and Siemens. He has extensive experience of being one of the first employees in a start-up and growing an organisation from the ground up and through M&As.

He has thorough experience of product conceptualisation, development and commercialisation, clinical collaborations and intellectual property management.

Ryan Hennen

VP US Sales

Ryan Hennen

VP US Sales

Ryan brings over 20 years of experience consulting with large Healthcare IDN's while helping deliver enterprise wide solutions to healthcare.

Ryan has experience with Imaging, Oncology, Value Based Care, Population Health, Clinical Decision Support, AI, NLP, and Machine Learning. He brings vast experience from the medical device and IT divisions of Canon / Toshiba and IBM Watson Health.

ADVISORS